Charléric Bornet

1.1k total citations
20 papers, 849 citations indexed

About

Charléric Bornet is a scholar working on Infectious Diseases, Molecular Medicine and Endocrinology. According to data from OpenAlex, Charléric Bornet has authored 20 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Molecular Medicine and 6 papers in Endocrinology. Recurrent topics in Charléric Bornet's work include Antibiotic Resistance in Bacteria (7 papers), Enterobacteriaceae and Cronobacter Research (5 papers) and Viral gastroenteritis research and epidemiology (2 papers). Charléric Bornet is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Enterobacteriaceae and Cronobacter Research (5 papers) and Viral gastroenteritis research and epidemiology (2 papers). Charléric Bornet collaborates with scholars based in France, Switzerland and New Zealand. Charléric Bornet's co-authors include Anne Davin‐Regli, C. Bollet, Jean‐Marie Pagès, Monique Malléa, Claude Bosi, Jacqueline Chevalier, R Jean, Gilles Kaplanski, Christophe Curti and Vanessa Pauly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Charléric Bornet

20 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charléric Bornet France 15 432 210 188 174 151 20 849
Teemu Kallonen Finland 20 488 1.1× 100 0.5× 333 1.8× 258 1.5× 75 0.5× 43 1.1k
Hao Chung The Vietnam 17 256 0.6× 334 1.6× 342 1.8× 316 1.8× 33 0.2× 30 1.1k
Norihisa Yamamoto Japan 17 313 0.7× 152 0.7× 173 0.9× 162 0.9× 67 0.4× 49 777
Sohei Harada Japan 19 507 1.2× 264 1.3× 235 1.3× 229 1.3× 106 0.7× 81 943
Xiaojü Lu China 15 348 0.8× 217 1.0× 167 0.9× 231 1.3× 68 0.5× 33 676
Genyan Liu China 16 234 0.5× 221 1.1× 184 1.0× 321 1.8× 33 0.2× 42 860
Daniela Scribano Italy 17 312 0.7× 200 1.0× 290 1.5× 364 2.1× 39 0.3× 41 1.0k
Karin van Dijk Netherlands 20 240 0.6× 468 2.2× 121 0.6× 240 1.4× 86 0.6× 63 1.6k
Bianca Graves Australia 8 421 1.0× 373 1.8× 118 0.6× 231 1.3× 352 2.3× 12 1.2k
Bei Li China 13 241 0.6× 96 0.5× 143 0.8× 228 1.3× 31 0.2× 32 723

Countries citing papers authored by Charléric Bornet

Since Specialization
Citations

This map shows the geographic impact of Charléric Bornet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charléric Bornet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charléric Bornet more than expected).

Fields of papers citing papers by Charléric Bornet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charléric Bornet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charléric Bornet. The network helps show where Charléric Bornet may publish in the future.

Co-authorship network of co-authors of Charléric Bornet

This figure shows the co-authorship network connecting the top 25 collaborators of Charléric Bornet. A scholar is included among the top collaborators of Charléric Bornet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charléric Bornet. Charléric Bornet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leroux, Pierre, Charléric Bornet, Jean‐Michel Bolla, & Anita Cohen. (2025). Challenges of Carbapenem-Resistant Enterobacteriaceae in the Development of New β-Lactamase Inhibitors and Antibiotics. Antibiotics. 14(6). 587–587. 2 indexed citations
2.
Primas, Nicolas, Guillaume Lano, Marion Sallée, et al.. (2023). Stability Study of Parenteral N-Acetylcysteine, and Chemical Inhibition of Its Dimerization. Pharmaceuticals. 16(1). 72–72. 6 indexed citations
3.
Cauchois, Raphaël, Marie Koubi, Julien Carvelli, et al.. (2020). Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19. Proceedings of the National Academy of Sciences. 117(32). 18951–18953. 150 indexed citations
4.
Curti, Christophe, et al.. (2018). Management of adult Clostridium difficile digestive contaminations: a literature review. European Journal of Clinical Microbiology & Infectious Diseases. 38(2). 209–231. 10 indexed citations
5.
Curti, Christophe, et al.. (2018). Chickenpox: An update. Médecine et Maladies Infectieuses. 49(1). 1–8. 14 indexed citations
6.
Curti, Christophe, et al.. (2017). Environmental monitoring by surface sampling for cytotoxics: a review. Environmental Monitoring and Assessment. 189(2). 52–52. 36 indexed citations
7.
Zandotti, Christine, Sophie Alain, Noémie Jourde‐Chiche, et al.. (2017). Brincidofovir Use after Foscarnet Crystal Nephropathy in a Kidney Transplant Recipient with Multiresistant Cytomegalovirus Infection. SHILAP Revista de lepidopterología. 2017. 1–7. 8 indexed citations
8.
Curti, Christophe, et al.. (2017). News on therapeutic management of MDR-tuberculosis: a literature review. Journal of Chemotherapy. 30(1). 1–15. 8 indexed citations
9.
Roche, Manon, et al.. (2016). Misuse of antibiotics reserved for hospital settings in outpatients: a prospective clinical audit in a university hospital in Southern France. International Journal of Antimicrobial Agents. 48(1). 96–100. 14 indexed citations
10.
11.
Sartor, Catherine, Charléric Bornet, Didier Guinard, & Pierre‐Edouard Fournier. (2013). Transmission of Aeromonas hydrophila by leeches. The Lancet. 381(9878). 1686–1686. 14 indexed citations
12.
Chiche, Laurent, N. Jourde, Julien Mancini, et al.. (2012). Seasonal variations of systemic lupus erythematosus flares in southern France. European Journal of Internal Medicine. 23(3). 250–254. 21 indexed citations
13.
Brah, Souleymane, Laurent Chiche, Charléric Bornet, et al.. (2011). Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey. Annals of Hematology. 91(2). 279–285. 15 indexed citations
14.
Frauger, Élisabeth, Vincent Pradel, Charléric Bornet, et al.. (2011). Use of intravenous immunoglobulins in clinical practice: data from three French university hospitals. Fundamental and Clinical Pharmacology. 25(6). 753–761. 18 indexed citations
15.
Bornet, Charléric, et al.. (2004). Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes. Biochemical and Biophysical Research Communications. 317(3). 851–856. 67 indexed citations
16.
Bornet, Charléric, et al.. (2004). Omp35, a New Enterobacter aerogenes Porin Involved in Selective Susceptibility to Cephalosporins. Antimicrobial Agents and Chemotherapy. 48(6). 2153–2158. 32 indexed citations
17.
Bornet, Charléric, Renaud Chollet, Monique Malléa, et al.. (2003). Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes. Biochemical and Biophysical Research Communications. 301(4). 985–990. 61 indexed citations
18.
Bornet, Charléric, Anne Davin‐Regli, Claude Bosi, Jean‐Marie Pagès, & C. Bollet. (2000). Imipenem Resistance of Enterobacter aerogenes Mediated by Outer Membrane Permeability. Journal of Clinical Microbiology. 38(3). 1048–1052. 116 indexed citations
19.
Bosi, Claude, Anne Davin‐Regli, Charléric Bornet, et al.. (1999). Most Enterobacter aerogenes Strains in France Belong to a Prevalent Clone. Journal of Clinical Microbiology. 37(7). 2165–2169. 92 indexed citations
20.
Malléa, Monique, Jacqueline Chevalier, Charléric Bornet, et al.. (1998). Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology. 144(11). 3003–3009. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teemu Kallonen Breakdown of academic impact, for papers by Hao Chung The Breakdown of academic impact, for papers by Norihisa Yamamoto Breakdown of academic impact, for papers by Sohei Harada Breakdown of academic impact, for papers by Xiaojü Lu Breakdown of academic impact, for papers by Genyan Liu Breakdown of academic impact, for papers by Daniela Scribano Breakdown of academic impact, for papers by Karin van Dijk Breakdown of academic impact, for papers by Bianca Graves Breakdown of academic impact, for papers by Bei Li
Rankless by CCL
2026